Salmonella Outbreak Under Investigation
The US Centers for Disease Control and Prevention (CDC) is investigating a Salmonella outbreak that had infected seven individuals across six states as of April 24, 2025.
According to the CDC website's information on the investigation, the first case of Salmonella Mbandaka in the current outbreak was reported on February 9, 2025, and nearly half of the cases involved children younger than 5 years. Five of the seven patients reported contact with backyard poultry prior to developing Salmonella infection. Public health officials are using the PulseNet system to identify other potential cases. The bacteria tested so far do not suggest challenges from antibiotic resistance, according to the CDC.
Tomatoes Not Yet Implicated, but Recalled
Although specific products have not yet been identified as the source of the outbreak, an Indiana-based company Ray & Mascari Inc is recalling 4 Count clam shell packages of Vine Ripe Tomatoes because of potential Salmonella contamination, according to a company announcement shared on the US Food & Drug Administration website.
No illnesses related to the tomatoes have been reported, but the potential presence of Salmonella in the facility that processes the tomatoes prompted the recall, according to the company announcement. Distributors who have received recalled tomatoes have been alerted, and consumers who purchased the products should discard them, according to the company.
Public Health Message Is Prevention
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
18 minutes ago
- Medscape
Fast Five Quiz: Opioid Use Disorder
Opioid use disorder (OUD) currently impacts approximately 16 million people worldwide. It is considered a significant public health issue, with experts noting a 'burden that is increasing' globally. As research into optimal management of OUD evolves, updates to clinical guidelines emphasize a more individualized approach to pharmacologic treatment, psychosocial support, and special considerations for specific patient populations, such as pregnant individuals. However, OUD remains a complex disease that comes with many serious health and legal concerns for both patients and clinicians. What do you know about OUD? Check your knowledge with this quick quiz. Despite pharmacologic treatment being known to be highly effective for treating OUD, a CDC report states that 30% of patients with OUD who require OUD treatment received only nonpharmacologic treatment. Further, 43% of patients did not perceive a need for OUD treatment at all. In this significant report, males aged 35-49 years were most likely to receive OUD treatment with medications, while females and younger and older adults had lower rates of access to pharmacologic interventions. The CDC concluded that engaging patients needing OUD treatment with pharmacologic interventions is 'essential.' Learn more about essential statistics for OUD. Data from a predictive-model study indicate that service setting was the strongest predictor for premature discontinuation of OUD treatment. The strength of this predictor declined with length of stay, becoming negligent after 365 days. Other system-level factors such as geographic region, primary source of payment for treatment, and referral source were also strong predictors of early discontinuation; individual factors such as age of first use, sex, and race were less predictive. Previous research cited by the study has also stressed the importance of reducing system-level barriers to care, and the updated federal guidance for opioid treatment programs have expanded access in several ways. Learn more about OUD guidance. Precipitated withdrawal can occur when transferring a patient from methadone to buprenorphine due to buprenorphine being only a partial opioid agonist; as such, the traditional method of transfer involves putting the patient in a controlled, moderate withdrawal state before initiating buprenorphine therapy. However, a novel dosing strategy called microinduction, which involves starting buprenorphine at submilligram doses (or 'low-dose induction'), and cross-tapering with methadone can prevent precipitated withdrawal. Additionally, this method is ideal for patients who want to switch from methadone to buprenorphine and those with chronic use of intravenous or intranasal fentanyl. A recent systematic review found that microinduction and traditional transfer methods had similar rates of successful induction of buprenorphine at 95.6%. Learn more about safe withdrawal practices for OUD. Both the CDC and the latest American Society of Addiction Medicine (ASAM) guidelines specifically state that pharmacotherapy for OUD should be offered as early as possible in pregnancy to prevent harms to both the patient and the fetus, noting that pharmacotherapy for OUD has been associated with improved maternal outcomes. ASAM specifically states, 'increasing the dose or split dosing is often required, especially in the third trimester.' Federal guidelines emphasize that pregnant individuals seeking treatment for OUD are considered a priority for enrollment in opioid treatment programs. Once receiving treatment, they do not generally recommended medically supervised withdrawal from pharmacotherapy for pregnant patients as it might harm the fetus and patient; further, ASAM guidelines state that patients who undergo medically supervised withdrawal are at an increased risk for 'return to opioid use.' However, if a patient decides to proceed with medically supervised withdrawal, ASAM guidelines suggest physicians provide education and resources regarding associated risks. The CDC also specifically recommends against abruptly discontinuing opioids during pregnancy, citing data and resources from the American College of Obstetricians and Gynecologists and the Substance Abuse and Mental Health Services Administration. Learn more about OUD. Federal guidelines specify that opioid treatment programs must conduct at least eight random drug tests per year on their patients. These tests must use FDA approved products that test for commonly abused substances that might affect patient safety, recovery, or adherence to OUD treatment. ASAM affirms this requirement, noting that many patients might need more frequent testing and that eight tests per year 'should be viewed as a minimum.' Learn more about drug testing in OUD. Editor's Note: This article was created using several editorial tools, including generative AI models, as part of the process. Human review and editing of this content were performed prior to publication.
Yahoo
33 minutes ago
- Yahoo
RFK Jr.'s newest CDC vaccine panel includes critics of COVID shots, lockdowns
The Brief U.S. Health Secretary Robert F. Kennedy Jr. has replaced the government's vaccine advisory panel with eight new appointees. The new members include vocal critics of COVID-19 vaccines and pandemic lockdowns, such as Dr. Robert Malone and Dr. Martin Kulldorff. Public health groups have raised concerns that Kennedy's changes could undermine long-standing vaccination policies. NEW YORK - U.S. Health Secretary Robert F. Kennedy Jr. has named eight new vaccine policy advisers to replace the panel that he abruptly dismissed earlier this week. His selections include a scientist who researched mRNA vaccine technology and transformed into a conservative darling for his criticisms of COVID-19 vaccines, and a leading critic of pandemic-era lockdowns. RELATED: RFK Jr. ousts entire CDC vaccine panel Kennedy made the announcement in a social media post on Wednesday. The backstory Kennedy's decision to "retire" the previous 17-member panel was widely decried by doctors' groups and public health organizations, who feared the advisers would be replaced by a group aligned with Kennedy's desire to reassess — and possibly end — longstanding vaccination recommendations. Dig deeper The new appointees to the Advisory Committee on Immunization Practices include Dr. Robert Malone, the former mRNA researcher who emerged as a close adviser to Kennedy during the measles outbreak. Malone, who runs a wellness institute and a popular blog, rose to popularity during the COVID-19 pandemic as he relayed conspiracy theories around the outbreak and the vaccines that followed. He has appeared on podcasts and other conservative news outlets where he's promoted unproven and alternative treatments for measles and COVID-19. He has claimed that millions of Americans were hypnotized into taking the COVID-19 shots. He's even suggested that those vaccines cause a form of AIDS. He's downplayed deaths related to one of the largest measles outbreaks in the U.S. in years. Other appointees include Dr. Martin Kulldorff, a biostatistician and epidemiologist who was a co-author of the Great Barrington Declaration, an October 2020 letter maintaining that pandemic shutdowns were causing irreparable harm. Dr. Cody Meissner, a former ACIP member, also was named. Big picture view The committee, created in 1964, makes recommendations to the director of the Centers for Disease Control and Prevention. CDC directors almost always approve those recommendations on how Food and Drug Administration-cleared vaccines should be used. The CDC's final recommendations are widely heeded by doctors and determine the scope of vaccination programs. The Source The Associated Press contributed to this report. The information in this story comes from a social media announcement made by U.S. Health Secretary Robert F. Kennedy Jr. on Wednesday, in which he introduced eight new members to the federal vaccine advisory panel. This story was reported from Los Angeles.
UPI
an hour ago
- UPI
RFK Jr. names 8 new CDC vaccine advisory members, including skeptics
June 11 (UPI) -- Two days after disbanding the entire 17-member independent vaccine advisory committee, Health and Human Services Secretary Robert F. Kennedy Jr. on Wednesday appointed eight new members, including prominent vaccine skeptics and pandemic response critics. CDC's Advisory Committee on Immunization Practices, or ACIP, is scheduled to meet next on June 25. The new panel included seven men and one woman. "The slate includes highly credentialed scientists, leading public-health experts, and some of America's most accomplished physicians," Kennedy said in a post on X. "All of these individuals are committed to evidence-based medicine, gold-standard science, and common sense. They have each committed to demanding definitive safety and efficacy data before making any new vaccine recommendations. The committee will review safety and efficacy data for the current schedule as well." On Monday, Kennedy said the former members had conflicts of interest on a panel that "wields the grave responsibility of adding new vaccines to the recommended childhood schedule." He pointed ties to Big Pharma. Kennedy, a long-time vaccine critic, said the "most outrageous example of ACIP's malevolent malpractice has been its stubborn unwillingness to demand adequate safety trials before recommending new vaccines for our children. ... ACIP has recommended each of these additional jabs without requiring placebo-controlled trials for any of them. This means that no one can scientifically ascertain whether these products are averting more problems than they are causing." CDC has narrowed its recommendations for mRNA Covid-19 shots, including by children and pregnant women. DHS spokesperson Andrew Nixon told NBC News that "all newly appointed ACIP members were thoroughly vetted" but declined to offer specifics. ACIP normally includes pediatricians, geriatricians and other vaccine experts but the new panel includes a psychiatrist, neuroscientist, epidemiologist and biostatistician, and professor of operations management. Kennedy released information on the new members. Dr. Robert Malone, a physician-scientist and biochemist, has been a vocal critic of mRNA technology in COVID-19 vaccines after making early innovations in the field of messenger RNA. He suggested this year, without evidence, that pediatric deaths from measles were due to medical error. He has served in advisory roles for the U.S. Department of Health and Human Services and the Department of Defense. "His expertise spans molecular biology, immunology, and vaccine development," Kennedy said. Dr. Martin Kulldorff, a biostatistician and epidemiologist, co-authored an October 2020 strategy on herd immunity known as the Great Barrington Declaration with Dr. Jay Bhattacharya, now director of the U.S. National Institutes of Health. He formerly was at Harvard Medical School, and served on Food and Drug Administration and CDC panels. "He has also been an influential voice in public health policy, advocating for evidence-based approaches to pandemic response," Kennedy said. Dr. Cody Meissner, a Dartmouth professor of pediatrics who also signed the Great Barrington Declaration, has served on ACIP and on the U.S. Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee. "His expertise spans vaccine development, immunization safety, and pediatric infectious disease epidemiology," Kennedy said. Dr. Joseph Hibbeln, a psychiatrist and neuroscientist, is former acting chief of the U.S. National Institutes of Health section on nutritional neurosciences. "His work has informed U.S. public health guidelines, particularly in maternal and child health," Kennedy said. "Dr. Hibbeln brings expertise in immune-related outcomes, psychiatric conditions, and evidence-based public health strategies." Dr. Retsef Levi, a Massachusetts Institute of Technology professor of operations management, has published studies on mRNA vaccines and cardiovascular events. "His research has contributed to discussions on vaccine manufacturing processes, safety surveillance, and public health policy," Kennedy said. He has been involved in healthcare systems optimization, epidemiologic modeling, and the application of AI and data science in public health. Dr. James Pagano, an emergency medicine physician with 40 years of clinical experience from "Level 1 trauma centers to small community hospitals, caring for patients across all age groups," Kennedy said in describing him as a "strong advocate for evidence-based medicine." He has served on hospital committees, including utilization review, and medical executive boards. Dr. Vicky Pebsworth, a pediatric professor at Dartmouth, is the Pacific region director of the National Association of Catholic Nurses. She has served on the FDA committee, as well as a national panel reviewing the 2009 H1N1 swine flu vaccine. "She has worked in the healthcare field for more than 45 years, serving in various capacities," Kennedy said. NBC News reported she is a leading source of misinformation about vaccines. Dr. Michael Ross, a professor of obstetrics and gynecology at George Washington University and Virginia Commonwealth University, has served on the CDC's Advisory Committee for the Prevention of Breast and Cervical Cancer. "His continued service on biotech and healthcare boards reflects his commitment to advancing innovation in immunology, reproductive medicine and public health," Kennedy said. Dr. Noel Brewer, an ACIP member who was fired this week, told MSNBC on Wednesday: "The new panel is missing all of the expertise that has come before them. They don't know how to go about looking at the evidence, how to think about the volumes of data that will be coming their way." Brewer, who said members should be replaced on a rolling basis, is a professor in the department of health behavior at the University of North Carolina Gillings School of Global Public Health. "Being a vaccine skeptic is not a bad thing if you follow the science," Dr. Georges Benjamin, executive director of the American Public Health Association, told NBC News. "I'm concerned that the names he's put out so far aren't ideologically balanced. I think he got the slate he was looking for." Benjamin said Kennedy's policies are a danger to public health.
